Paydirt
TENX
Ticker

Tenax Therapeutics, Inc.

TENX · Healthcare · Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States

Tenax Therapeutics, Inc. (TENX), in the Healthcare sector, has 5 disclosed filings on Paydirt over the trailing twelve months from 2 corporate insiders: 5 purchases and 0 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Oct 21 and filed Oct 21. The most active filer was ADAR1 Capital Management, LLC with 4 filings. Data as of Nov 8 2026.

Add to watchlist
Filings, ttm
5
5 buys · 0 sells
Traders, ttm
2
2 insiders
Volume, ttmiDollar value disclosed in the window
$6.4M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Oct 21
Filed Oct 21
ADViAverage daily dollar volume
$7.2M
market data
Share price · 12M
$1.72 (-75.4%)
$18.32$9.84$1.36Nov 10 2025May 6Oct 27

Adjusted for splits and dividends.

Volume by month
$3.1M$1.5M$0Dec 2024Jun 2025Dec 2025Jun 2026Aug 2026 · buys $1.8MSep 2026 · buys $3.1MOct 2026 · buys $1.5M
Buys $6.4M Sells $0

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months
AL ADAR1 Capital Management, LLC 10% owner 4 filings · 4 buys, 0 sales DD Declan Doogan Director 1 filing · 1 buy, 0 sales
Recent filings
ADAR1 Capital Management, LLCPURCHASE 10% owner $1.5M
922,849 sh across 3 lots
Exec Oct 19
Filed Oct 21 · 4:49 PM ET Declan DooganPURCHASE Director $102K
53,000 sh × $1.92
Exec Sep 16
Filed Sep 17 · 9:30 PM ET ADAR1 Capital Management, LLCPURCHASE 10% owner $1.6M
900,000 sh × $1.78
Exec Sep 3
Filed Sep 8 · 5:16 PM ET ADAR1 Capital Management, LLCPURCHASE 10% owner $1.4M
770,333 sh across 3 lots
Exec Aug 31
Filed Sep 2 · 5:52 PM ET ADAR1 Capital Management, LLCPURCHASE 10% owner $1.8M
1,025,867 sh across 3 lots
Exec Aug 20
Filed Aug 24 · 6:12 PM ET